After two years of euphoria, 2023 reflected a correction in the investment market that tied up most of the capital. However, investors predict an increase in the number and quality of operations for 2024, according to Study on investment in the Life Sciences and Healthcare industry in Catalonia 2023, prepared by CataloniaBio & HealtTech and EY, and presented today as part of the second edition of Connection Day, in La Farga de L'Hospitalet de Llobregat.

REIG JOFRE, member of CataloniaBio & HealthTech, hosted a visit at its state-of-the-art plant to produce hospital-use injectable drugs, from the Minister of Industry and Tourism, Jordi Hereu Boher, accompanied by Jordi García Brustenga, Director General of Industrial Strategy and Small and Medium Enterprises; and the mayor of Sant Joan Despí, Belén García. 

G&L Healthcare Advisors has announced the appointment of Dr. Steven Hildemann, MD, PhD, as a Non-Executive Director. Acting in an advisory capacity, Dr. Hildemann will bring his invaluable expertise to G&L as the company continues to expand globally and pursue strategic acquisitions. 

Ysios Capital, member of CataloniaBio & HealthTech, has announced its participation in the Swiss company MEMO Therapeutics funding round expansion of 20 million Swiss Francs (€20.5M). 

Longevitas Labs, the first Spanish laboratory specialized in aging prevention, partners with Made of Genes, member of CataloniaBio & HealthTech, to present the innovative Personalized Bio-Genetic Study. 

SocialDiabetes, member of CataloniaBio & HealthTech, announces the launch of "Listen.Doctor", an AI-powered tool that transforms medical consultations into actionable knowledge. 

Google.org has announced that it will invest 200,000 euros in an artificial intelligence (AI) project focused on improving cancer patients called GrowAI by HumanITcare, member of CataloniaBio & HealthTech. 

The BC Link platform, developed by the biotechnology company Better Care, member of CataloniaBio & HealthTech, will be the first technology to be evaluated using the parameters agreed upon by all participants in the ASSESS-DHT project, which aims to standardize and harmonize the evaluation of Digital Health Technologies across Europe. 

CataloniaBio & HealthTech is launching a new space for analysing current affairs to give a voice to our main asset: the organisations and companies that are part of the association. A new opinion forum to make us stop and reflect on the effects that changes in the environment may have on companies in the health sector. On 13 March 2024, lawmakers in the European Parliament approved by majority vote a new law to regulate AI systems, the first-ever legal framework on artificial intelligence. This is what Casper Wilstrup, CEO of Abzu, has to say on the matter.

Mowoot, member of CataloniaBio & HealthTech, launched a project in collaboration with Eurecat, also members, and the Jordi Gol i Gurina Primary Care Research Foundation to develop a device that becomes the first effective therapy for the treatment of IBS. 

Medichem, member of CataloniaBio & HealthTech, is pleased to announce the appointment of Pablo Álvarez as its new Chief Executive Officer (CEO). With an excellent track record in the pharmaceutical industry and a commitment to lead Medichem into a new phase of growth and success. 

The Josep Carreras Leukaemia Research Institute, member of CataloniaBio & HealthTech, opens a new lab with the incorporation of Dr. Vincenzo Calvanese, a consolidated researcher on stem cell biology. The new group will try to understand which molecular features and regulatory processes identify a blood stem cell, a fundamental knowledge to advance in many areas, like haematopoietic stem cell transplant, one of the few successful clinical applications of stem cells today. 

Ship2B Ventures, member of CataloniaBio & HealthTech, is driving 10 pioneering impact startups in the healthcare field through the BSocial Impact Fund, supported by Banc Sabadell, the European Investment Fund and Axis. 

Oncoheroes Biosciences, member of CataloniaBio & HealthTech, announce a significant milestone in its mission to combat pediatric brain cancer. In a recent paper published in SLAS Discovery journal titled "Development of a High-Throughput Screening Platform to Identify New Therapeutic Agents for Medulloblastoma Group 3" authored by Inés Fallon, Henar Hernando, Olga Almacellas-Rabaiget, Berta Marti-Fuster, Cesare Spadoni, Darell D Bigner, and Eva Méndez, their team reveals the development of an innovative screening platform aimed at identifying potential drug candidates for medulloblastoma, a type of brain cancer prevalent in children 

Croda Pharma, member of CataloniaBio & HealthTech, has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived squalene for the vaccine industry. 

Reig Jofre, member of CataloniaBio & HealthTech, announces an investment of 5.8 million euros in the biotechnological company Leanbio, also a member. This investment aims at vertical integration in the development, characterization, and production of biotechnological-based active ingredients. 

Some of the member companies of CataloniaBio & HealthTech have been recognised by the 500 startups that are revolutionising the healthcare sector. 

Professionals from the Hospital Sant Joan de Déu Barcelona shared the clinical needs they have identified in their daily work in paediatric care with around sixty attendees from around thirty companies and start-ups from CataloniaBio & HealthTech and the sector. It was held on the afternoon of Tuesday 9 April at the Auditori Plaza de l'Hospital Sant Joan de Déu. 

The Catalan biotechnology company GoodGut, part of the HIPRA group and a member of CataloniaBio & HealthTech, has developed a solution to improve the detection of alterations in the intestinal microbiota. It has published the results of a clinical study demonstrating that the use of its test in colorectal cancer screening reduces false positives by 20%. This would contribute to a better optimization of the available resources in the healthcare system, as it would reduce the number of unnecessary colonoscopies and avoid the discomfort of undergoing this procedure if it is not strictly necessary.  

The Josep Carreras Institute (IJC), member of CataloniaBio & HealthTech, has received the provisional resolution of accreditation as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation and Universities. The IJC is one of the 10 institutions that have received accreditation in the 2023 call, placing it among the best research centers in the country based on excellence, scientific contributions, talent attraction capacity, and economic and social impact, among others.